Cargando…

Pharmacophore mapping approach to find anti-cancer phytochemicals with metformin-like activities against transforming growth factor (TGF)-beta receptor I kinase: An in silico study

The most frequently prescribed first-line treatment for type II diabetes mellitus is metformin. Recent reports asserted that this diabetes medication can also shield users from cancer. Metformin induces cell cycle arrest in cancer cells. However, the exact mechanism by which this occurs in the cance...

Descripción completa

Detalles Bibliográficos
Autores principales:	Reza, Rumman, Morshed, Niaz, Samdani, Md. Nazmus, Reza, Md. Selim
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2023
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10635513/ https://www.ncbi.nlm.nih.gov/pubmed/37943796 http://dx.doi.org/10.1371/journal.pone.0288208

Ejemplares similares

Targeting SARS-CoV-2 non-structural protein 13 via helicase-inhibitor-repurposing and non-structural protein 16 through pharmacophore-based screening
por: Samdani, Md. Nazmus, et al.
Publicado: (2022)

In silico activity and ADMET profiling of phytochemicals from Ethiopian indigenous aloes using pharmacophore models
por: Bultum, Lemessa Etana, et al.
Publicado: (2022)

In Silico Design of Human IMPDH Inhibitors Using Pharmacophore Mapping and Molecular Docking Approaches
por: Li, Rui-Juan, et al.
Publicado: (2015)

Expression of transforming growth factor beta (TGF beta) receptors and expression of TGF beta 1, TGF beta 2 and TGF beta 3 in human small cell lung cancer cell lines.
por: Damstrup, L., et al.
Publicado: (1993)

In silico identification of T-type calcium channel blockers: A ligand-based pharmacophore mapping approach
por: Gandhi, Tamanna, et al.
Publicado: (2016)

Metformin is a novel suppressor for transforming growth factor (TGF)-β1
por: Xiao, Han, et al.
Publicado: (2016)

In silico Discovery of Novel FXa Inhibitors by Pharmacophore Modeling and Molecular Docking
por: Pu, Yinglan, et al.
Publicado: (2017)

Immunoregulatory role of transforming growth factor beta (TGF-beta) in development of killer cells: comparison of active and latent TGF-beta 1
Publicado: (1990)

Novel Transforming Growth Factor-Beta Receptor 1 Antagonists through a Pharmacophore-Based Virtual Screening Approach
por: Jiang, Junhao, et al.
Publicado: (2018)

Identification of novel natural drug candidates against BRAF mutated carcinoma; An integrative in-silico structure-based pharmacophore modeling and virtual screening process
por: Dain Md Opo, F. A., et al.
Publicado: (2022)

An In-Silico Identification of Potential Flavonoids against Kidney Fibrosis Targeting TGFβR-1
por: Rahman, MD. Hasanur, et al.
Publicado: (2022)

Osteoblasts synthesize and respond to transforming growth factor-type beta (TGF-beta) in vitro
Publicado: (1987)

Transporter associated with antigen processing 1 (TAP1) expression and prognostic analysis in breast, lung, liver, and ovarian cancer
por: Tabassum, Anika, et al.
Publicado: (2021)

Evaluation of tea (Camellia sinensis L.) phytochemicals as multi-disease modulators, a multidimensional in silico strategy with the combinations of network pharmacology, pharmacophore analysis, statistics and molecular docking
por: Nag, Anish, et al.
Publicado: (2022)

Design, Synthesis, In Silico and POM Studies for the Identification of the Pharmacophore Sites of Benzylidene Derivatives
por: Hosen, Mohammad I., et al.
Publicado: (2023)

Elevated plasma levels of transforming growth factor (TGF)-beta1 and TGF-beta2 in patients with disseminated malignant melanoma.
por: Krasagakis, K., et al.
Publicado: (1998)

The Insight of In Silico and In Vitro evaluation of Beta vulgaris phytochemicals against Alzheimer’s disease targeting acetylcholinesterase
por: Rehman, Sidra, et al.
Publicado: (2022)

In Silico Repositioning of Dopamine Modulators with Possible Application to Schizophrenia: Pharmacophore Mapping, Molecular Docking and Molecular Dynamics Analysis
por: Mejia-Gutierrez, Melissa, et al.
Publicado: (2021)

Regulation of Trypanosoma cruzi infections in vitro and in vivo by transforming growth factor beta (TGF-beta)
Publicado: (1991)

The role of transforming growth factor-beta (TGF-beta) during ovarian follicular development in sheep
por: Juengel, Jennifer L, et al.
Publicado: (2004)

Pharmacophore Synergism in Diverse Scaffold Clinches in Aurora Kinase B
por: Masand, Vijay H., et al.
Publicado: (2022)

Transforming Growth Factor-Beta (TGFβ) Signaling Pathway in Cholangiocarcinoma
por: Papoutsoglou, Panagiotis, et al.
Publicado: (2019)

Pharmacophore modeling, docking and molecular dynamics simulation for identification of novel human protein kinase C beta (PKCβ) inhibitors
por: Starosyla, Sergiy A., et al.
Publicado: (2022)

Transforming growth factor beta 1 (TGF-beta 1) induced neutrophil recruitment to synovial tissues: implications for TGF-beta-driven synovial inflammation and hyperplasia
Publicado: (1991)

Pharmacophoric-constrained heterogeneous graph transformer model for molecular property prediction
por: Jiang, Yinghui, et al.
Publicado: (2023)

Selective DNA Gyrase Inhibitors: Multi-Target in Silico Profiling with 3D-Pharmacophores
por: Tomašič, Tihomir, et al.
Publicado: (2021)

Staphylococcus aureus Enterotoxin B Down-Regulates the Expression of Transforming Growth Factor-Beta (TGF-β) Signaling Transducers in Human Glioblastoma
por: Akbari, Abolfazl, et al.
Publicado: (2016)

Analysis of SYK Gene as a Prognostic Biomarker and Suggested Potential Bioactive Phytochemicals as an Alternative Therapeutic Option for Colorectal Cancer: An In-Silico Pharmaco-Informatics Investigation
por: Biswas, Partha, et al.
Publicado: (2021)

Transforming growth factor beta (TGF-β) in adolescent chronic fatigue syndrome
por: Wyller, Vegard Bruun, et al.
Publicado: (2017)

Identification of novel anti-amoebic pharmacophores from kinase inhibitor chemotypes
por: Ferrins, Lori, et al.
Publicado: (2023)

A transforming growth factor beta 2 (TGF-beta 2)-like immunosuppressive factor in amniotic fluid and localization of TGF-beta 2 mRNA in the pregnant uterus
Publicado: (1990)

Pharmacophore modeling and in silico toxicity assessment of potential anticancer agents from African medicinal plants
por: Ntie-Kang, Fidele, et al.
Publicado: (2016)

Isolation of phytochemical constituents from Stevia rebaudiana (Bert.) and evaluation of their anticancer, antimicrobial and antioxidant properties via in vitro and in silico approaches
por: Khatun, Most. Chand Sultana, et al.
Publicado: (2021)

Hsp90 inhibition differentially destabilises MAP kinase and TGF-beta signalling components in cancer cells revealed by kinase-targeted chemoproteomics
por: Haupt, Armin, et al.
Publicado: (2012)

In-silico screening for anti-Zika virus phytochemicals
por: Byler, Kendall G., et al.
Publicado: (2016)

Critical review on Rumex dentatus L. a strong pharmacophore and the future medicine: Pharmacology, phytochemical analysis and traditional uses
por: Khaliq, Tahirah, et al.
Publicado: (2023)

Mapping Disease Transmission Risk of Nipah Virus in South and Southeast Asia
por: Deka, Mark A., et al.
Publicado: (2018)

Transforming Growth Factor-Beta (TGF-β) Signaling in Cancer-A Betrayal Within
por: Baba, Abdul Basit, et al.
Publicado: (2022)

Receptor-Based Pharmacophore Modeling in the Search for Natural Products for COVID-19 M(pro)
por: Saeed, Mohd, et al.
Publicado: (2021)

Reappraisal of screening strategy in hepatitis B surface antigen-negative blood donors: Correlation with hepatitis B virus-DNA quantification
por: Alam, Md. Sohrab, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_gmjjjmjlhem0d88hle8qbtjb18